3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
21
Myelodysplastic Syndromes
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Myeloproliferative Disorders
6
Lymphoma, Non-Hodgkin
5
Leukemia
5
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Hodgkin Disease
4
Anemia, Refractory, with Excess of Blasts
4
Multiple Myeloma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Graft vs Host Disease
3
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Preleukemia
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurofibromatosis 1
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Busulfan
×
90 days
×
Clear all
No trials found.